Lambda Wins Award
 Read More


Learn more about our current studies.
Read more

International Services


Pharmacovigilance:

 

From its UK offices, Lambda provides a full range of Pharmacovigilance (PV) services that offer a cost-effective solution to maintain the PV function without the cost of in-house staff and resources.  Team backed by quality approach and flexibility, assures efficacy while delivering services. 

 

Lambda Therapeutic Research uses the quality assured and 21 CRF Part 11 solutions for collecting, storing, maintaining, retrieving and managing Adverse Event (AE) Data and for generating various regulatory reports.

 

Visit website.

 

 

Preclinical Services:


Located in Libertyville, IL, USA, Nia Life Sciences, Inc. is a sister company of LTR.  NIA provides services for toxicology, pharmacokinetics and metabolism.

 

Studies in rodents are performed in full compliance with Good Laboratory Practice (GLP) regulations. In addition, all protocols are designed to meet client's needs and the regulatory requirements.

 

Visit website.

 

 

ECG Core Laboratory:

 

The ECG Core laboratory at Lambda India has been designed to provide centralized digital and manual ECG data analysis for QT/QTc studies conducted in-house at Lambda and for clinical trials conducted at investigative sites.

 

ECG Core Lab utilizes the latest in digital technology supported by the GE MUSE platform to provide high quality data that will support your trial objectives and the emerging regulatory requirements for digital acquisition, transmission and archival of ECG’s.

 

Visit website.

 

 

Central Reference Laboratory


The central lab at Lambda Therapeutic Research has vast experience working for various clinical trials involving specialties like COPD, CVS, Oncology, Diabetes, CNS, Orthopaedic, etc. and PK studies of macromolecule e.g. LMWH.

 

Visit website.

 

Phase I Clinical Trials

 

Lambda Therapeutic Research has the expertise to offer you the entire range of services for First-in-man and Phase I clinical trials.  Our capabilities lie in designing the protocol, conducting the study, generation of the clinical study report and the regulatory submission.

 

Visit website.

 

 

Phase II-IV Clinical Trials:


Lambda India has experience with Phase II to IV studies, ranging from single center studies with 20 patients to large trials with over 5,000 patients.  Operations are regionally based in India and locally managed across Central & Eastern Europe.

 

Visit website.



Website Designed by Clutch Marketing